Get the Stockscreener App
87.84
0.43%
0.38
After Hours:
87.84
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $87.84, with a volume of 1.00M.
It is up +0.43% in the last 24 hours and down -9.97% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$87.46
Open:
$88.66
24h Volume:
1.00M
Relative Volume:
0.76
Market Cap:
$9.82B
Revenue:
$2.86B
Net Income/Loss:
$239.88M
P/E Ratio:
42.02
EPS:
2.0903
Net Cash Flow:
$506.94M
1W Performance:
+3.43%
1M Performance:
-9.97%
6M Performance:
+5.78%
1Y Performance:
-18.20%
1-Day Range:
$86.28
$89.74
1-Week Range:
$83.67
$89.74
52-Week Range:
$81.36
$118.30
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
87.84 | 9.78B | 2.86B | 239.88M | 506.94M | 2.0903 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Research Alert: CFRA Maintains Buy Rating On Shares Of Revvity, Inc. - Moomoo
Revvity Inc. stock faces pressure amid life sciences sector slowdown and looming Q4 earnings test - AD HOC NEWS
Is Revvity stock underperforming the S&P 500? - MSN
Revvity Inc. stock faces pressure amid life sciences sector slowdown and acquisition integration cha - AD HOC NEWS
Bull Bear: Can Revvity Inc outperform in the next rally2026 Weekly Recap & Weekly Watchlist of Top Performers - baoquankhu1.vn
Why is Revvity (RVTY) down 5.1% since last earnings report? - MSN
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Revvity Inc a play on infrastructure spendingMarket Performance Recap & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Tudor Investment Corp ET AL Acquires New Shares in Revvity Inc. $RVTY - MarketBeat
Reassessing Revvity (RVTY) Valuation After Strong Q4 Results And Weaker Guidance Versus Peers - simplywall.st
Revvity Inc. stock faces pressure amid life sciences slowdown and acquisition integration challenges - AD HOC NEWS
Swing Trade: What is the cash position of Revvity Inc2026 Stock Rankings & Risk Controlled Stock Alerts - baoquankhu1.vn
Revvity declares $0.07 dividend - MSN
Guggenheim Initiates Coverage of Revvity (RVTY) with Neutral Recommendation - MSN
JPMorgan Chase & Co. Grows Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Why (RVTY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN
Revvity, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Is Revvity Stock Underperforming the S&P 500? - Barchart.com
Research Tools & Consumables Stocks Q4 Results: Benchmarking Revvity (NYSE:RVTY) - Yahoo Finance
Revvity blends creativity and robotics at Shanghai site for New Year festivities - Traders Union
Emerald Growth Equity Strategy sold Revvity (RVTY) in Q4 - MSN
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity (RVTY) awards stock options and RSUs to officer Anita Gonzales - Stock Titan
Here's why you should retain Revvity stock in your portfolio for now - MSN
Revvity Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Tranche Update on Revvity, Inc.'s Equity Buyback Plan announced on October 27, 2025. - marketscreener.com
REVVITY, INC. ($RVTY) CEO 2025 Pay Revealed - Quiver Quantitative
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
John Chevedden Submits Shareholder Proposal to Revvity - marketscreener.com
Revvity Receives Shareholder Proposal from John Chevedden - marketscreener.com
Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4 - Insider Monkey
[ARS] REVVITY, INC. SEC Filing - Stock Titan
Revvity (RVTY) 2026 proxy outlines virtual meeting, 10 directors and governance votes - Stock Titan
Revvity Inc. (NYSE:RVTY) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
EdgePoint Investment Group Inc. Acquires 1,784,620 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity Inc. Stock (ISIN: US76155R1086) Faces Headwinds in Diagnostics Amid Life Sciences Recovery - AD HOC NEWS
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revvity (RVTY) and Candel Therapeutics (CADL) - The Globe and Mail
Stifel reiterates Hold on Revvity stock, keeps $110 price target By Investing.com - Investing.com India
Stifel reiterates Hold on Revvity stock, keeps $110 price target - Investing.com
Korea Investment CORP Sells 29,300 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Sold by Capital Research Global Investors - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Barclays PLC Sells 37,149 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity at Conference Barclays: Strategic Insights for Growth By Investing.com - Investing.com India
Revvity at Conference Barclays: Strategic Insights for Growth - Investing.com
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity (RVTY) awards officer Anita Gonzales stock options and RSUs - Stock Titan
Understanding Momentum Shifts in (RVTY) - Stock Traders Daily
Dimensional Fund Advisors LP Purchases 596,436 Shares of Revvity Inc. $RVTY - MarketBeat
How The Revvity (RVTY) Narrative Is Shifting With Higher Targets And Tempered Growth Assumptions - Yahoo Finance
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):